Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Kebomed Oy
OY
Active
Y-tunnus 2391997-6
Äyritie 12A, 01510
Vantaa
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2011 · 15 years old
11 employees
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Kebomed Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
9M
7M
4M
2M
0M
2021: 6M
6M
2021
2022: 6M (0% vs 2021)
6M
0%
2022
2023: 6M (0% vs 2022)
6M
0%
2023
2024: 6M (0% vs 2023)
6M
0%
2024
2025: 7M (+17% vs 2024)
7M
+17%
2025
EBITDA
EUR millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
6 695
6 207
6 008
5 738
5 718
Staff expenses
−1 230
−1 135
−1 019
−957
−884
EBITDA
399
555
680
816
1 107
Depreciation & amort.
−0
−0
−0
—
—
EBIT
399
555
680
816
1 107
Net financials
29
42
30
−1
1
Profit before tax
428
597
710
815
1 107
Tax
87
121
145
166
223
Net profit
341
476
565
648
884
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
4 448
4 721
4 305
2 948
2 331
Equity
3 762
3 421
2 945
2 380
1 731
Long-term debt
0
0
0
—
—
Short-term debt
686
1 300
1 360
568
600
Total debt
686
1 300
1 360
568
600
Financial ratios
5-year trend
EBITDA margin
6,0 %
This company
15,8 %
Market median
This company
Market median
62% below market
2021
2025
Equity ratio
84,6 %
This company
38,2 %
Market median
This company
Market median
121% above market
2021
2025
Return on equity
9,1 %
This company
18,4 %
Market median
This company
Market median
51% below market
2021
2025
Net profit margin
5,1 %
This company
8,1 %
Market median
This company
Market median
37% below market
2021
2025
Asset turnover
1,51×
This company
1,12×
Market median
This company
Market median
35% above market
2021
2025
Debt / equity
0,18×
This company
0,62×
Market median
This company
Market median
71% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-07-01 – 2021-06-30
View
PDF
More on Kebomed Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
